Images List Premium Download Classic

Cardiovascular

Cardiovascular-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Biomarkers and methods of prediction
Hoffmann-la Roche Inc.
November 09, 2017 - N°20170322225

Subject of the present invention are biomarkers and methods for the identification of risk for subsequent cardiovascular event (e. G. Coronary heart disease death, non-fatal myocardial infarction, ischemic stroke, hospitalizations for unstable angina pectotis, cardiac arrest) in patients that have experienced an acute coronary syndrome, comprising the detecting the level of nt-probnp, homocysteine and crp.
Measurement of serum lipoproteins
Vap Diagnostics Laboratory Inc.
November 09, 2017 - N°20170322135

Although a more accurate estimate of a person's risk of cardiovascular disease can be made on the basis of the number of lipoprotein particles per unit volume in the person's blood, current methods all rely on measuring the mass of lipoprotein cholesterol per unit volume. It has been discovered that a rapid and accurate lipoprotein particle count can be obtained ...
Amide-substituted pyridinyltriazole derivatives and uses thereof
Bayer Pharma Aktiengesellschaft
November 09, 2017 - N°20170320854

The present invention relates to novel 5-(carboxamide)-1-pyridinyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Preparation containing chlorogenic acid crystal form and use thereof
Sichuan Jiuzhang Biological Science And Technology Co., Ltd.
November 09, 2017 - N°20170319530

A preparation containing a chlorogenic acid crystal form. The crystal form is an orthorhombic crystal system, a space group is p212121, cell parameters are as follows: a=7. 7291(2)Å, b=10. 9808(2)Å, c=36. 5334(7)Å, α=β=γ=90. 00°, z=8, and a cell volume is 3100. 65(11)Å3. The content of the chlorogenic acid crystal form in the ...
Apparatus and method for extracting cardiovascular characteristic
Samsung Electronics Co., Ltd.
November 09, 2017 - N°20170319146

An apparatus for extracting a cardiovascular characteristic is provided. The apparatus may include: a first sensor configured to measure a vibration signal generated by a pulse wave of a subject; a second sensor configured to measure a pulse wave signal of the subject; a processor configured to perform an operation related to a cardiovascular characteristic on the basis of the ...
Modulation of the vps10p-domain receptors for the treatment of cardiovascular disease
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170318057

The present invention relates to methods for modulating the activity of one or more vps10p-domain receptors selected from the group consisting of sortilin, sorla, sorcs1, sorcs2 and sorcs3, in an animal and methods for preparation of a medicament for the treatment of abnormal plasma lipid concentrations and associated diseases and/or disorders. The modulation is carried out by inhibiting ...
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Fused heterocyclic compounds as selective bmp inhibitors
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170313701

The present invention provides small molecule inhibitors of bmp signaling. These compounds may be used to modulate cell growth, differentiation, proliferation, and apoptosis, and thus may be useful for treating diseases or conditions associated with bmp signaling, including inflammation, cardiovascular disease, hematological disease, cancer, and bone disorders, as well as for modulating cellular differentiation and/or proliferation.
Substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines and their use
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170313700

The present application relates to novel substituted pyrazolo[1,5-a]pyridines and imidazo[1,2-a]pyrazines, to processes for preparation thereof, to the use thereof, alone or in combinations, for treatment and/or prophylaxis of diseases, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially for treatment and/or prophylaxis of cardiovascular disorders.
Hydroxyalkyl-substituted phenyltriazole derivatives and uses thereof
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170313665

The present invention relates to novel 5-(hydroxyalkyl)-1-phenyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular and renal diseases.
Method for the synthesis of hydroxy-triglycerides and uses thereof for the prevention and treament of ...
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170313646

The present invention relates to hydroxy-triglycerides, their synthesis, a pharmaceutical and/or nutraceutical composition which comprises at least one of said hydroxy-triglycerides, and a method which comprises the administration to a patient of a therapeutically effective quantity of at least one of said hydroxy-triglycerides or at least one of said pharmaceutical and/or nutraceutical compositions, for the prevention and/or ...
Systems and methods for coordinating musculoskeletal and cardiovascular or cerebrovascular hemodynamics
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312612

Described herein are methods for determining a target musculoskeletal activity cycle (mskc) to cardiac cycle (cc) timing relationship. The method may include detecting a first characteristic of a signal responsive to a cc timing of a user that repeats at a frequency that corresponds to a heart rate of the user; detecting a second characteristic of a signal responsive to ...
Multi-threshold sensing of cardiac electrical signals in an extracardiovascular implantable cardioverter defibrillator
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312534

An implantable medical device system capable of sensing cardiac electrical signals includes a sensing circuit, a therapy delivery circuit and a control circuit. The sensing circuit is configured to receive a cardiac electrical signal and sense a cardiac event in response to the signal crossing a cardiac event sensing threshold. The therapy delivery circuit is configured to deliver an electrical ...
System and method for sensing and detection in an extra-cardiovascular implantable cardioverter defibrillator
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312532

An extra-cardiovascular implantable cardioverter defibrillator senses r-waves from a first cardiac electrical signal by a first sensing channel and stores a time segment of a second cardiac electrical signal in response to each sensed r-wave. The icd determines intervals between successively sensed r-waves and, in response to at least a predetermined number of the intervals being less than a tachyarrhythmia ...
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Implant for use in the cardiovascular system
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312504

An implant for the cardiovascular system is provided, the implant is insertable into an organ and includes a body structure configured to be disposed inside an organ; and an electret coating disposed on the body structure; wherein the electret coating includes a negative charge such that a negative electrostatic field is formed in proximity of the body structure, the charge ...
Method for enhanced uptake of viral vectors in the myocardium
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312373

The present invention relates to improved therapies for the treatment of heart disease, particularly the improved delivery of therapeutic agents to heart tissue by direct infusion into the coronary circulation. A preferred embodiment of the invention is a method of treating or preventing a cardiovascular disease by transfecting cardiac cells of a large mammal, the method comprising, identifying a mammal ...
Methods for treating patients with familial hypercholesterolemia
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312359

The present invention provides methods for treating patients suffering from familial hypercholesterolemia, including both hefh and hofh. The methods of the invention provide for lowering at least one lipid parameter in the patient by administering a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds to angptl3 in combination with a therapeutically effective amount of a ...
Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for ...
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312338

A method for classifying patients at risk for cardiovascular disease, other chronic inflammatory diseases, cardiovascular and/or non-cardiovascular morbidity and mortality based on a risk assessment for lymphocyte activation gene 3 (lag3) protein deficiency, and for mediating the risk using recombinant lymphocyte activation gene-3 or lag3 mimetic as a companion therapeutic alone or in combination with a statin and/or an ...
Use of nitrite salts in chronic ischemia
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312310

Methods of treating a subject who has chronic tissue ischemia are disclosed. The methods can include administering to the subject a pharmaceutical composition comprising inorganic nitrite or a pharmaceutically acceptable salt thereof, for a time and in an amount sufficient to result in blood vessel growth in the ischemic tissue. The subject can be diagnosed as having a medical condition ...
Systems, apparatus and methods for sealing perivalvular leaks
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170312074

An expandable support member comprising an ecm composition that is configured to engage an interior region of a prosthetic valve and capable of transitioning from a pre-deployment configuration, where the support member is capable of being positioned at an interior valve region of the valve when the valve is disposed at a cardiovascular valve structure, to a post-deployment configuration when ...
Cardio-respiratory fitness assessment
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170311883

Methods and systems for assessing cardio-respiratory fitness (crf) with the use of body motion data is disclosed. Specific measurements of body movement (for example, motion amplitude or velocity, or distance covered during repetitive displacement) are dependent on a user's fitness level. Embodiments prompt the user to execute a simple set of periodic movements which can be used to estimate cardiovascular ...
Measuring psychological stress from cardiovascular and activity signals
Samsung Electronics Co., Ltd.
November 02, 2017 - N°20170311862

A method and system for measuring psychological stress disclosed. In a first aspect, the method comprises determining r-r intervals from an electrocardiogram (ecg) to calculate a standard deviation of the r-r intervals (sdnn) and determining a stress feature (sf) using the sdnn. In response to reaching a threshold, the method includes performing adaptation to update a probability mass function (pmf). ...
Loading